Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

  1. Goetz, M.P.
  2. Martin, M.
  3. Tokunaga, E.
  4. Park, I.H.
  5. Huober, J.
  6. Toi, M.
  7. Stoffregen, C.
  8. Shekarriz, S.
  9. Andre, V.
  10. Gainford, M.C.
  11. Price, G.L.
  12. Johnston, S.
Aldizkaria:
Oncologist

ISSN: 1549-490X,  1083-7159

Argitalpen urtea: 2020

Alea: 25

Zenbakia: 9

Orrialdeak: e1346-e1354

Mota: Artikulua

DOI: 10.1634/THEONCOLOGIST.2020-0084 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus